Antimitotic Agents: all 5,052 studies that test it

Page 49 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid TumorCompletedNCT00004243Phase 1
• Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachCompletedNCT00004235Phase 2
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerCompletedNCT00004223Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerTerminatedNCT00004221Phase 2
• Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00004202Phase 2
• Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerCompletedNCT00004175Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerCompletedNCT00004174Phase 1
• Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable CancerStatus unknownNCT00004173Phase 1
• Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the NasopharynxStatus unknownNCT00004164Phase 2
• Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's LymphomaCompletedNCT00004162Phase 1
• Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid TumorTerminatedNCT00004159Phase 1/2
• Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00004139Phase 2
• S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004137Phase 2
• Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung CancerCompletedNCT00004126Phase 2
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00004105Phase 1/2
• Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerStatus unknownNCT00004100Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerStatus unknownNCT00004097Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or LarynxStatus unknownNCT00004094Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTerminatedNCT00004093Phase 1/2
• Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial TumorsCompletedNCT00004082Phase 1
• Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00004081Phase 2
• Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular CancerCompletedNCT00004077Phase 2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaCompletedNCT00004066Phase 2
• Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasCompletedNCT00004057Phase 1
• Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004055Phase 2
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerTerminatedNCT00004037Phase 2
• Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast CancerCompletedNCT00004013Phase 2
• S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00004011Phase 3
• Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's DiseaseCompletedNCT00004010Phase 2
• S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00004001Phase 3
• Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial CancerCompletedNCT00003998Phase 3
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver CancerCompletedNCT00003994Phase 3
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell TransplantationCompletedNCT00003963Phase 2
• Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerCompletedNCT00003953Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00003944Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.CompletedNCT00003943Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaCompletedNCT00003935Phase 1
• Dolastatin 10 in Treating Patients With Advanced Kidney CancerCompletedNCT00003914Phase 2
• S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003908Phase 2
• Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone InvolvementCompletedNCT00003902Phase 1/2
• Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerCompletedNCT00003900Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003888Phase 3
• Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid TumorsCompletedNCT00003882Phase 1
• Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00003881Phase 2
• Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal CancerTerminatedNCT00003880Phase 2/3
• Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the EsophagusCompletedNCT00003864Phase 2
• Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNSCompletedNCT00003859Phase 3
• VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung CancerTerminatedNCT00003847Phase 2
• Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsCompletedNCT00003846Phase 2
• S9804: Vinorelbine in Treating Patients With Stage IV MelanomaCompletedNCT00003828Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00003812Phase 2
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNCT00003810Phase 2
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic LeukemiaCompletedNCT00003783Phase 2
• Docetaxel in Treating Patients With Stage IV Prostate CancerCompletedNCT00003781Phase 2
• Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaCompletedNCT00003778Phase 2
• Combretastatin A4 Phosphate in Treating Patients With Advanced Solid TumorsCompletedNCT00003768Phase 1
• Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003762Phase 2
• Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid TumorCompletedNCT00003755Phase 1
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00003742Phase 1
• Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian CancerStatus unknownNCT00003733Phase 2
• Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian CancerCompletedNCT00003732Phase 2
• Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast CancerCompletedNCT00003730Not applicable
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate CancerStatus unknownNCT00003717Phase 2
• Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00003709Phase 1
• BMS-184476 in Treating Patients With Advanced Solid TumorsCompletedNCT00003705Phase 1
• Combination Chemotherapy in Treating Patients With Bladder CancerCompletedNCT00003701Phase 3
• Chemotherapy in Treating Patients With Solid TumorsCompletedNCT00003698Phase 1
• Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00003693Phase 1
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00003691Phase 3
• Dolastatin 10 in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00003677Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaCompletedNCT00003671Phase 2
• Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaCompletedNCT00003667Phase 2
• Combination Chemotherapy in Treating Men With Germ Cell CancerStatus unknownNCT00003643Phase 2/3
• Combination Chemotherapy in Treating Patients With Advanced Prostate CancerStatus unknownNCT00003633Phase 1
• Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone TherapyCompletedNCT00003626Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem GliomaCompletedNCT00003625Phase 1
• Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerTerminatedNCT00003624Phase 2
• Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone TherapyWithdrawnNCT00003622Phase 2
• Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate CancerCompletedNCT00003614Phase 2
• Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00003612Phase 2
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003592Phase 3
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerCompletedNCT00003591Phase 2
• S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003587Phase 2
• Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney CancerCompletedNCT00003584Phase 2
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerCompletedNCT00003582Phase 1/2
• Docetaxel in Treating Patients With Solid TumorsCompletedNCT00003565Phase 2
• Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerStatus unknownNCT00003562Phase 2
• Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00003560Phase 2
• Chemotherapy in Treating Patients With Cancer of Unknown Primary OriginStatus unknownNCT00003558Phase 3
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder CancerCompletedNCT00003557Phase 2
• Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00003555Phase 1
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00003539Phase 2
• Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell TumorsCompletedNCT00003518Phase 2
• Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003493Phase 2
• Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple MyelomaCompletedNCT00003490Phase 2
• Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT00003449Phase 2
• Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerStatus unknownNCT00003447Phase 3
• Docetaxel in Treating Patients With Advanced Cancer of the CervixCompletedNCT00003445Phase 2

← Antimitotic Agents overview